Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan

• Prif Awduron: Akemi Egami (Awdur), Shinji Takahashi (Awdur), Takeshi Kokubo (Awdur), Sreedevi Boggarapu (Awdur), Eric Beresford (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Adis, Springer Healthcare, 2023-03-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Abstract Introduction Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disorder affecting several organs, including skin. We sought to assess the real-world effectiveness and safety of a topical sirolimus 0.2% gel treatment for TSC-related cutaneous manifestations. Methods We co...